AU4765390A - 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals. - Google Patents

5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals.

Info

Publication number
AU4765390A
AU4765390A AU47653/90A AU4765390A AU4765390A AU 4765390 A AU4765390 A AU 4765390A AU 47653/90 A AU47653/90 A AU 47653/90A AU 4765390 A AU4765390 A AU 4765390A AU 4765390 A AU4765390 A AU 4765390A
Authority
AU
Australia
Prior art keywords
oxazolidinones
pharmaceuticals
substituted phenyl
phenyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47653/90A
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU4765390A publication Critical patent/AU4765390A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B1/00—Engines characterised by fuel-air mixture compression
    • F02B1/02—Engines characterised by fuel-air mixture compression with positive ignition
    • F02B1/04—Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU47653/90A 1984-10-19 1990-01-04 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals. Abandoned AU4765390A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3438839 1984-10-19
DE19843438839 DE3438839A1 (en) 1984-10-19 1984-10-19 PHARMACEUTICAL PREPARATIONS

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU50958/85A Division AU5095885A (en) 1984-10-19 1985-10-18 Pharmaceutical preparations

Publications (1)

Publication Number Publication Date
AU4765390A true AU4765390A (en) 1990-05-03

Family

ID=6248597

Family Applications (2)

Application Number Title Priority Date Filing Date
AU50958/85A Abandoned AU5095885A (en) 1984-10-19 1985-10-18 Pharmaceutical preparations
AU47653/90A Abandoned AU4765390A (en) 1984-10-19 1990-01-04 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU50958/85A Abandoned AU5095885A (en) 1984-10-19 1985-10-18 Pharmaceutical preparations

Country Status (8)

Country Link
EP (1) EP0198919B1 (en)
JP (2) JPH0742229B2 (en)
AU (2) AU5095885A (en)
DE (2) DE3438839A1 (en)
DK (1) DK167531B1 (en)
FI (1) FI862590A (en)
NO (1) NO164897C (en)
WO (1) WO1986002268A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
DE3639225A1 (en) * 1986-11-14 1988-05-19 Schering Ag USE OF 5- (SUBST. PHENYL) -OXAZOLIDINONE DERIATES AS PSYCHOPHARMAKA
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
EP0334674B1 (en) * 1988-03-24 1994-06-01 Sankyo Company Limited Use of isoxazolinones as cerebro-active drugs
AU8292091A (en) * 1990-08-03 1992-03-02 Smithkline Beecham Corporation Tnf inhibitors
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
CZ290671B6 (en) * 1995-02-10 2002-09-11 Schering Aktiengesellschaft Pharmaceutical preparations intended for inhibition of tumor necrosis factor
DE19540475A1 (en) * 1995-10-20 1997-04-24 Schering Ag Chiral methylphenyloxazolidinones
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
KR100951218B1 (en) * 2001-10-16 2010-04-05 메모리 파마슈티칼스 코포레이션 4-4-Alkoxy-3-Hydroxyphenyl-2-Pyrrolidone Derivatives as PDE-4 Inhibitors for the Treatment of Neurological Syndromes
WO2004098592A1 (en) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. Composition containing oxazolidinone derivative
AR057218A1 (en) 2005-12-15 2007-11-21 Astra Ab OXAZOLIDINONE COMPOUNDS AND THEIR USE AS PONTENCIATORS OF THE METABOTROPIC GLUTAMATE RECEIVER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413935A1 (en) * 1974-03-20 1975-10-16 Schering Ag 4- (POLYALCOXY-PHENYL) -2-PYRROLIDONE
SU888821A3 (en) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs
DE2655369A1 (en) * 1976-12-03 1978-06-08 Schering Ag 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION

Also Published As

Publication number Publication date
JPH0742229B2 (en) 1995-05-10
EP0198919B1 (en) 1990-02-28
JPS62501289A (en) 1987-05-21
JP2669494B2 (en) 1997-10-27
DE3438839A1 (en) 1986-04-24
FI862590A0 (en) 1986-06-17
WO1986002268A1 (en) 1986-04-24
NO164897C (en) 1990-11-28
FI862590A (en) 1986-06-17
DK288686A (en) 1986-06-19
NO862439L (en) 1986-06-18
DE3576118D1 (en) 1990-04-05
DK288686D0 (en) 1986-06-19
EP0198919A1 (en) 1986-10-29
NO164897B (en) 1990-08-20
JPH0761978A (en) 1995-03-07
NO862439D0 (en) 1986-06-18
AU5095885A (en) 1986-05-02
DK167531B1 (en) 1993-11-15

Similar Documents

Publication Publication Date Title
AU568004B2 (en) Antibacterial 1,4 hydro-quinolines and 1,8-napthridines
GB2159516B (en) Azaphthalocyanines and their use as photoactivators
AU4177785A (en) Polyaminodithiols and radiopharmaceuticals
AU560184B2 (en) Polyampholites and their use
AU4765390A (en) 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals.
EP0164018A3 (en) Chromogenic 4,4-diaryl-dihydroquinazolones, their preparation and use
AU4752785A (en) 13-halo and 13 hydroxymilbemycins
AU574817B2 (en) 3-carbonyl-1-aminoalkyl-1h-indoles and their use as analgesics
EP0180190A3 (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
AU528710B2 (en) Hexahydro-trans and tetrahydropyridoindole
AU6292286A (en) N-substituted-3,4,5,6,-tetrahydrophthalimides, their preparation and use
AU555675B2 (en) Aminopropylpivalamides and their use in making 2-6-butyl- 1,4,5,6-tetrahydropyrimidine
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
AU581445B2 (en) N-arylsulfonyl-N'-triazinylureas and N-arylsulfonyl-N'- pyrimidinylureas
AU5420986A (en) 2,3,4-triacylhexoses and mixtures thereof
AU3454984A (en) 1,z-dithiolanes and pharmaceutical compositions
AU6697086A (en) Immunoamplifiers and related compositions
AU587646B2 (en) 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
AU590422B2 (en) Substituted quinoxalinediones and quinolinediones
AU568750B2 (en) Imidazo-pyrrolo-pyridines and their use as herbacides
AU549459B2 (en) 1-(trihalomethyl-sulfenyl)-4-aryl-1,2,4-triazolidin-5- ones and fungici-des containing same
AU2681888A (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines
EP0193608A4 (en) Gif-2 and its preparation.
EP0172233A4 (en) Punaglandins and pharmaceutical use thereof.
AU5178486A (en) 1,3,4-trisubstituted azacyloalkanes and azacycloalkenes